HARBIN, China, May 13 CSKI-Team-Change
HARBIN, China, May 13 /Xinhua-PRNewswire-FirstCall/ -- China Sky One
Medical, Inc. (OTC Bulletin Board: CSKI; "China Sky" or "the Company"), a
China based manufacturer, marketer and distributor of pharmaceutical,
medicinal and diagnostic products, announced today the changes in management
team. The changes were made in conjunction with the Company filing an
application to list its shares on the American Stock Exchange.
As of May 7, 2008, Mr. Haifeng "Steve" Wang resigned as a secretary and
member of the Board of Directors (the "Board") of China Sky One Medical, Inc.
for personal reasons and Ms. Xiaoyan Han resigned as Chief Financial Officer
and was appointed as Vice Chairman of the Board.
Simultaneously, Mr. Xiaoqing Liao was appointed to the Board and was
appointed as Chief Financial Officer and Secretary of the Company and to
similar positions with the Company's operating subsidiaries.
Xiaoqing Liao has been employed with the company in various capacities
since March 2008. From 2005 to 2008, he worked as an acting Corporate
Secretary for Zhongjin Gold Corporation, a PRC state-owned company listed on
the Shanghai Stock Exchange, where he assisted with various restructuring
efforts. Prior to Zhongjin, Mr. Liao was a law clerk in the Law Department of
China National Gold Group, a large mining company controlled by the Central
State-Owned Asset Committee, where his responsibilities included reporting
directly to senior management on international economic and trade issues. From
2003 to 2004, he worked as investment manager for Unisar Avionics LTD, an
international trading company in the United Kingdom. Mr. Liao earned a
certification from the Shanghai Stock Exchange to act as a company secretary
for companies listed on such exchange in the PRC. He graduated from the
Zhongnan University of Economic and Law where he received a Bachelor or Arts
degree in law with a minor in accounting and international finance in 2003. Mr.
Liao also studied for one and half years in University of Newcastle upon Tyne
in the United Kingdom, where he received a Merit LLM degree in international
economics, international finance law and international accounting in 2004.
"China Sky One strives to achieve the high standards in financial
reporting as required by a U.S. listed public company. We look forward to
working with our newly appointed CFO and Board Secretary whom we hope will be
able to continue to represent the interests of all our shareholders throughout
the world and continue to deliver outstanding returns for our shareholders,"
said Mr. Yan-qing Liu, Chairman, CEO and Director of China Sky One Medical,
Inc.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a China based
company engaged in the manufacturing, marketing and distribution of
pharmaceutical, medicinal and diagnostic kit products. Through its wholly-
owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company
and Harbin First Bio-Engineering Company Limited the Company manufactures and
distributes over-the-counter pharmaceutical products as its primary revenue
source. For more information, visit http://www.skyonemedical.com .
Safe Harbor Statement
Certain statements made in the press release constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act
of 1995. These statements can be identified by the use of forward-looking
terminology such as "believe," "expect," "may," "will," "should," "project,"
"plan," "seek," "intend," or "anticipate" or the negative thereof or
comparable terminology. Additional statements that are necessarily forward
looking in nature also include, without limitation, statements relating to our
research and development activities, expected revenues or sales margins,
results of recent acquisitions and our ability to increase sales and expand
our presence in the global market place, and risks or uncertainties relating
to PRC socioeconomic issues. Such statements typically involve risks and
uncertainties and may include financial projections or information regarding
our future plans, objectives or performance. The Company cannot provide any
assurance that it will be able to establish listing of its securities on any
national or regional securities exchange or market system. Actual results
could differ materially from the expectations reflected in such forward-
looking statements as a result of a variety of factors, including the
inability of the company to meet listing standards of an exchange, risks
associated with the effect of changing economic conditions in The People's
Republic of China, variations in cash flow, reliance on collaborative retail
partners both in China and throughout the world and on new product development,
variations in new product development, risks associated with rapid
technological change, and the potential of introduced or undetected flaws and
defects in products, and other risk factors detailed in reports filed with the
Securities and Exchange Commission from time to time.
For more information, please contact:
China Sky One Medical, Inc.
Mr. Liao Xiaoqing, CFO
Tel: +86-1591-067-2198
Email: tdrhan@163.com
CCG Elite Investor Relations Inc.
Mr. Crocker Coulson, President
Tel: +1-646-213-1915 (New York)
Email: crocker.coulson@ccgir.com
Website: http://www.ccgelite.com
SOURCE China Sky One Medical, Inc.
